Fibrinolytics are indeed risky agents to use as they are non-selective in where clots are lysed. To give you a perspective, an injury from a fall from the initial stroke event is likely to re-bleed once fibrinolytics are administered. Patients sometimes bleed around the IV site when the med is running.
These meds need be given within 3-6 hours of stroke onset, depending on who you ask and what heroics you want to accomplish. After the six hour mark, you’re facing the same risks of disability from an iatrogenic bleed versus little gain from therapy because hypoxic tissue is dead at that point.
However, before that window closes, there is significant benefit in doing something versus nothing in stroke. It’s great when the use of the agent results in no deficits. The same can be said when the results are only limited deficits (i.e. use of a cane) versus a wheelchair or admission to long-term care.
These meds need be given within 3-6 hours of stroke onset, depending on who you ask and what heroics you want to accomplish. After the six hour mark, you’re facing the same risks of disability from an iatrogenic bleed versus little gain from therapy because hypoxic tissue is dead at that point.
However, before that window closes, there is significant benefit in doing something versus nothing in stroke. It’s great when the use of the agent results in no deficits. The same can be said when the results are only limited deficits (i.e. use of a cane) versus a wheelchair or admission to long-term care.